Here's Why Bausch Health Stock Gained 14.7% in a Week
BHC stock rises 14.7% in a week after a report surfaced that the company is in talks with Jefferies Financial Group to push ...
Sale Rumors Lift Both Bausch + Lomb And Parent Bausch Health - A Breakthrough Is Likely
Bausch Health is rumored to be looking to sell its Bausch + Lomb business, which will ease bankruptcy concerns and upgrade ...
Irish Examiner on MSN5d
Bausch Health Taps Jefferies to Refinance Debt, Aid Spinoff
Bausch Health Cos. is working with Jefferies Financial Group to explore refinancing some of its debt to aid a long-planned ...
Op-ed: Here’s why a sale of Bausch + Lomb could lead to a windfall for Bausch Health investors
Hedge fund managers sit on the boards of Bausch Health and Bausch + Lomb. They don’t think like your typical corporate board, ...
The Financial Times6d
Private equity suitors line up for Bausch + Lomb eyecare auction
Bausch + Lomb was put up for sale after a planned separation from its parent company Bausch Health, formerly known as Valeant ...
Buy Rating Reaffirmed for Bausch Health on Prospective Bausch + Lomb Sale and Value Unlocking
Analyst Glen Santangelo of Jefferies reiterated a Buy rating on Bausch Health Companies (BHC – Research Report), reducing the price ...
Plastics News6d
Kickstart: Focusing on a possible big deal in eye care
Consumer medical giant Bausch + Lomb may be preparing to sell off its eye care business, which would include contact lens ...
Nasdaq4d
Bausch (BHC) Surges 11.7%: Is This an Indication of Further Gains?
Bausch Health (BHC) shares rallied 11.7% in the last trading session to close at $8.02. This move can be attributable to notable volume with a higher number of shares being traded than in a ...
Jefferies Reaffirms Their Buy Rating on Teva Pharmaceutical (TEVA)
In a report released today, Glen Santangelo from Jefferies maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with ...